FindMyKOL
Clinical trialNCT02342977WithdrawnPhase 2Interventional

Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty:

NCT02342977 is a phase 2 interventional trial sponsored by Indiana University. As of 21 Nov 2026, it was withdrawn. It studies Lacosamide and Placebo in Avascular Necrosis, Osteoarthritis and 1 more condition. The registry lists an enrollment of 0 participants at 1 site in 1 country. The registry lists a start date of 30 Nov 2014 and a primary completion date of 31 Aug 2016.

SponsorIndiana University →Enrollment0Avascular NecrosisOsteoarthritisRheumatoid Arthritis
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02342977
FieldValue
Registry IDNCT02342977
StatusWithdrawn
PhasePhase 2
Study typeInterventional trial
Lead sponsorIndiana University
Enrollment0
Registered sites1
Countries1
ConditionsAvascular Necrosis, Osteoarthritis and Rheumatoid Arthritis
DrugsLacosamide and Placebo
Start30 Nov 2014
Primary completion31 Aug 2016
Study completion31 Aug 2016
Last update posted26 Aug 2016

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine how effect lacosamide is in reducing the amount of pain medication needed following a total hip arthroplasty. The study team hypothesizes that a single dose of lacosamide will reduce the amount of pain medication required after surgery. The study team plans to evaluate the amount of pain medication needed and quality of pain control during a subject's hospital stay and at their three month follow-up visit following their surgery.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Indiana, United States1 site
  • Richard L. Roudebush Veterans Affairs Medical Center

    Indianapolis

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndiana: 1 siteIN1OhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT02342977

Each answer restates registry values shown on this page.

What is NCT02342977?

NCT02342977 is a phase 2 interventional trial sponsored by Indiana University. It studies Lacosamide and Placebo in Avascular Necrosis, Osteoarthritis and 1 more condition.

Who leads NCT02342977?

The registry names Bryan M Sakamoto, M.D., PhD (principal investigator, Richard L. Roudebush VA Medical Center) as the overall official.

Where does NCT02342977 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT02342977 study?

The registered drug and biological interventions are Lacosamide and Placebo.

When did NCT02342977 end?

The registry lists a primary completion date of 31 Aug 2016 and a study completion date of 31 Aug 2016. The sponsor last updated the record on 26 Aug 2016.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.